title: Self-reported Sleep Improvement in Buprenorphine MAT (Medication Assisted Treatment) Population.
abstract: This is a prospective, naturalistic study to evaluate patient's report on sleep and depression in early recovery while receiving buprenorphine in Medication Assisted Treatment (MAT). 40 Subjects entering into MAT with buprenorphine/naloxonefor opioid dependence disorder were recruited. No change of concurrent treatment was made. Subjects were administered Sleep Scale from the Medical Outcomes Study (MOS-Sleep), a 5-item Supplemental Sleep Scale (SSS), and the Beck Depression Inventory II (BDI-II). The measures were administered at day 0 (baseline), 30, 60 and 90 days. The result showed that patients reported significant progressive improvements in three MOS-Sleep subscales: sleep disturbance, sleep indices I and II. The mean scores of SLPD4 (Sleep disturbance) at day 0, 30, 60, 90 were 62.4, 53.2, 53.3, and 48.4 respectively (p=0.0029). Similarly, subscores of SLP6 (Sleep Problem Index I) and SLP 9 (Sleep Problem Index II) were also significantly decreased over time (P=0.038 for SLP6 and p=0.007 for SLP9). BDI-II depression scores improved from "Moderate depression" at baseline to "Mild depression". The mean BDI score decreased from 24.2 to 17.0 after 90 days of treatment. Findings suggest that subjects reported improvement in both sleep and depression after initiating MAT with buprenorphine/naloxone.
authors.affiliation: Department of Behavioral Medicine and Psychiatry, West Virginia University, USA.
authors.forename: W H
authors.initials: WH
authors.lastname: Zheng
authors.affiliation: Department of Behavioral Medicine and Psychiatry, West Virginia University, USA.
authors.forename: R J
authors.initials: RJ
authors.lastname: Wakim
authors.affiliation: Department of Behavioral Medicine and Psychiatry, West Virginia University, USA.
authors.forename: R C
authors.initials: RC
authors.lastname: Geary
authors.affiliation: Department of Behavioral Medicine and Psychiatry, West Virginia University, USA.
authors.forename: L R
authors.initials: LR
authors.lastname: Lander
authors.affiliation: Department of Biostatistics, West Virginia University, USA.
authors.forename: S J
authors.initials: SJ
authors.lastname: Wen
authors.affiliation: Department of Biostatistics, West Virginia University, USA.
authors.forename: M C
authors.initials: MC
authors.lastname: Xiao
authors.affiliation: Department of Behavioral Medicine and Psychiatry, West Virginia University, USA.
authors.forename: C R
authors.initials: CR
authors.lastname: Sullivan
keywords: BDI-II; Buprenorphine; Depression; MAT; MOS-Sleep; Sleep